Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey.
Indian J Ophthalmol. 2012 Jan-Feb;60(1):35-40. doi: 10.4103/0301-4738.90490.
To compare the status of corneal endothelium and central corneal thickness within the first four postoperative years after deep anterior lamellar keratoplasty (DALK) and penetrating keratoplasty (PK) in patients with keratoconus.
Thirty-nine eyes (Group A) which had PK and 44 eyes (Group B) which had DALK for the treatment of keratoconus were included in this retrospective study. The endothelial cell density (ECD), the mean endothelial cell area and the coefficient of variation of cell area were assessed with a non-contact specular microscope, and the central corneal thickness (CCT) was measured with an ultrasound pachymeter.
Mean ECD loss rate at two years was 36.24% in Group A and 18.12% in Group B (P<0.001). Mean ECD loss rate at four years was 47.82% in Group A and 21.62% in Group B (P<0.001). Mean annual ECD loss rate was calculated 14.12% per year in Group A and 5.78% per year in Group B. In the PK group, increase in mean CCT was 15.60% in two years and 15.03% in four years, while in the DALK group, mean CCT increased by 8.05% in two years and 9.31% in four years.
As the majority of ectatic disorders such as keratoconus occur in young people, long-term endothelial cell survival following treatment with keratoplasty is essential for the long-term visual ability. Our finding that corneal endothelial cell loss in the DALK group occurs at a slower rate than in the PK group suggests DALK as a safer alternative to PK in these selected patients.
比较圆锥角膜患者行深板层角膜移植术(DALK)和穿透性角膜移植术(PK)后 4 年内角膜内皮细胞和中央角膜厚度的状况。
本回顾性研究纳入 39 只行 PK(A 组)和 44 只行 DALK(B 组)治疗圆锥角膜的患眼。应用非接触式共焦显微镜评估内皮细胞密度(ECD)、平均内皮细胞面积和细胞面积变异系数,应用超声角膜测厚仪测量中央角膜厚度(CCT)。
A 组术后 2 年平均 ECD 丢失率为 36.24%,B 组为 18.12%(P<0.001)。A 组术后 4 年平均 ECD 丢失率为 47.82%,B 组为 21.62%(P<0.001)。A 组平均每年 ECD 丢失率为 14.12%,B 组为 5.78%。PK 组术后 2 年和 4 年平均 CCT 分别增加 15.60%和 15.03%,而 DALK 组分别增加 8.05%和 9.31%。
由于大多数扩张性疾病,如圆锥角膜,发生在年轻人中,因此角膜移植术后长期的内皮细胞存活对于长期的视力能力至关重要。我们发现 DALK 组角膜内皮细胞丢失的速度比 PK 组慢,这表明在这些选择的患者中,DALK 是 PK 的一种更安全的替代方法。